Kanda Biotechnology
As of the edition of 20 October 2026, Kanda Biotechnology runs 2 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Status not established | 2 |
| Total | 2 |
Where its trials are
- Skin and connective tissue: 2 trials led
- Bones, joints and muscles: 1 trials led
- Cancer: 1 trials led